News
This is where our journey begins. Get to know our business and what we do, and how we're committed to quality and great service. Join us as we grow and succeed together. We're glad you're here to be a part of our story.
RSV vaccine- update 2026
National Immunisation Program - Update
From 15 May 2026, the Respiratory Syncytial Virus (RSV) vaccine Arexvy® will be funded under the National Immunisation Program (NIP) for eligible older adults at increased risk of severe RSV disease.
Eligible populations
From 15 May 2026, a single dose of Arexvy® will be funded for:
- Adults aged 75 years and older
- Aboriginal and Torres Strait Islander peoples aged 60–74 years
Dose schedule
- Currently, only a single dose of the RSV vaccine is recommended for older adults, and protection lasts at least 2 years.
- No booster dose is recommended for older adults vaccinated against RSV in 2025.
Clinical guidance
- Arexvy® may be given at the same visit as other vaccines for older adults, including COVID‑19, influenza (including adjuvanted influenza), pneumococcal and shingles vaccines.
- Refer to the Australian Immunisation Handbook and NCIRS RSV FAQs for clinical guidance.
- Australian Government resources for health professionals and consumers will be made available in the coming weeks.
- All Arexvy® vaccinations must be reported to the Australian Immunisation Register.
NOTE - Arexvy® vaccine is not registered for use in children.
Flu vaccine is available from 1/4/2026 at Premium Care Medical Centre St Albans and Sunshine North.
Identify NIP eligible patients: Free Flu Vaccine
Review your patient cohort in your health service and assess how many patients are:
• children aged six months to less than five years
• Aboriginal and Torres Strait Islander people aged 6 months and over
• pregnant women, at any stage of pregnancy
• people aged 6 months and over with certain medical risk conditions for severe influenza disease
• people aged 65 years and older.
Medical risk conditions covered under the NIP:
- Previous episode of invasive pneumococcal disease
- Functional or anatomical asplenia
- Immunocompromising conditions
- Proven or presumptive cerebrospinal fluid (CSF) leak
- Chronic respiratory disease
- Chronic renal disease
- Cardiac disease
- Children born less than 28 weeks gestation
- Chromosomal abnormality.
Talk to your health professional about your eligibility for a free pneumococcal vaccine and if you or your children need additional vaccinations.